XLO

7.4301.07%
NM

Nathan McBride

Chief Information Officer

Mr. Nathan McBride is Chief Information Officer of Xilio Therapeutics, Inc. from September 2022, bringing more years of information technology leadership experience to support the company’s mission of developing tumor-activated immuno-oncology therapies. Prior to joining Xilio, Mr. McBride served as Vice President of IT at Affinivax, a clinical-stage biotechnology company focused on next-generation vaccine development, where he led the technological re-acquisition of key digital assets following the company’s acquisition by GSK in September 2022. Mr. McBride received a B.A. in Classics from Connecticut College and holds numerous professional certifications, including Certified Lean Six Sigma Black Belt from Villanova University and Google Cybersecurity Professional certification. He completed the MIT Technology Leadership Program at MIT Sloan School of Management and holds master certifications in various enterprise software platforms.

Positions